Skip to search formSkip to main contentSkip to account menu

heptaplatin

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
The intermolecular forces between anti–cancer molecules such as Cisplatin, Carboplatin, Oxaliplatin, Nedaplatin, Lobaplation… 
2012
2012
Objective To compare toxicity of a new platinum complax LLC-0601 with Cisplatin and heptaplatin on Human fetal liver cell(L-02… 
2011
2011
OBJECTIVE To investigate the hepatotoxicity of heptaplatin and LLC-0601 in SD rats,and to explore the toxic mechanisms.METHODS… 
2009
2009
Purpose: Heptaplatin (SKI-2053 R) is a new platinum analogue, with a better toxicity profile than cisplatin, and has antitumor… 
2006
2006
Heptaplatin, a new platinum derivative, has several contradicting reports on the nephrotoxicity. Therefore, the aim of this study… 
2005
2005
2039 Background: On a 4-week schedule, the maximal tolerated dose (MTD) for single heptaplatin (H), a less toxic platinum analog… 
2004
2004
Background : This study was performed in patients with advanced or recurrent gastric cancer to evaluate the efficacy and… 
2004
2004
【A wide variety of cancer chemotherapeutic agents have been shown to induce programmed cell death (PCD, APOPTOSIS) in various… 
2003
2003
PURPOSE Heptaplatin (SKI-2053R, Sunpla ), a new platinum analogue which has a better toxicity profile than cisplatin, has been… 
2003
2003
PURPOSE Heptaplatin, a new platinum analog, has favorable toxicity profiles and antitumor activity, comparable to those of…